U.S. Online Retail and Ecommerce Stock News

NYSE:TSN
NYSE:TSNFood

Is Tyson Foods (TSN) Pricing Look Attractive After Recent Share Price Softness?

If you are wondering whether Tyson Foods at around US$63.68 is a bargain or a value trap, the key is to look past the headline share price and into what the current valuation actually reflects. The stock has slipped about 0.5% over the last week and 1.0% over the last month, but is still showing a 9.7% return year to date and 8.5% over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on Tyson Foods as a major player in U.S...
NasdaqGS:LI
NasdaqGS:LIAuto

A Look At Li Auto (NasdaqGS:LI) Valuation After Recent Share Price Weakness

Recent share performance and business snapshot Li Auto (NasdaqGS:LI) has drawn attention after recent share price moves, with the stock last closing at US$17.57 and showing mixed return patterns over the past year. Short term performance has been weak, with a 1 day return of 1.46% decline, a 7 day return of 3.09% decline, and a month return of 4.41% decline. Over the past 3 months, the stock shows a 5.65% gain, while the year to date return is 1.86%. Looking over the past year, Li Auto’s...
NasdaqGM:KIDS
NasdaqGM:KIDSMedical Equipment

OrthoPediatrics (KIDS) Q1 Losses Challenge Bullish Margin Narratives Despite 11.1% Revenue Growth

OrthoPediatrics (KIDS) opened Q1 2026 with revenue of US$59.4 million and a basic EPS loss of US$0.45, while trailing 12 month figures show revenue of US$243.3 million and a basic EPS loss of US$1.68 as the company continues to operate in the red. Over the past reported periods, revenue has moved from US$52.7 million in Q4 2024 to a range of roughly US$59 million to US$61.6 million through Q1 2026. Quarterly basic EPS has stayed loss making between about US$0.30 and US$0.69 per share. For...
NYSE:COLD
NYSE:COLDIndustrial REITs

A Look At Americold Realty Trust’s (COLD) Valuation As Governance Challenges Intensify Before The Annual Meeting

Americold Realty Trust (COLD) is under heightened scrutiny after Sieve Capital and proxy advisor Egan Jones urged shareholders to vote against seven incumbent directors, including the chairman, citing governance concerns and reported conflicts of interest. See our latest analysis for Americold Realty Trust. Americold’s share price has been volatile, with a 9.35% 1 month share price return contrasting with a 5.10% year to date share price decline and a 32.29% 1 year total shareholder return...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta Expands Beyond Ads With Humanoid Robots And Next Generation Energy

Meta Platforms (NasdaqGS:META) is moving into humanoid robotics with the acquisition of Assured Robot Intelligence. The company is also expanding its energy efforts through partnerships focused on space-based solar power and ultra-long-duration storage for AI infrastructure. Both developments are recent and add new elements to Meta's existing focus on social platforms, AI and data centers. For investors, these moves widen the scope of what Meta Platforms is trying to build beyond its core...
NasdaqGS:XEL
NasdaqGS:XELElectric Utilities

Xcel Energy’s US$4.3b Equity Raise And What It Means For Valuation

Xcel Energy, NasdaqGS:XEL, has launched a follow on equity offering totaling $4.3b in new common stock. The company is raising a substantial amount of capital that is separate from routine earnings or guidance updates. Xcel Energy is coming to market with a large equity raise at a time when its shares last closed at $82.58. The stock has logged a 20.4% return over the past year and is up 10.6% year to date, alongside gains of 4.3% over the past week and 3.6% over the past month. For...
NYSE:MWA
NYSE:MWAMachinery

A Look At Mueller Water Products (MWA) Valuation As Shares Trade Below Narrative Fair Value

Mueller Water Products: Stock Moves and Business Snapshot Mueller Water Products (MWA) has been drawing fresh attention after recent share price moves, with the stock showing a small year to date gain alongside mixed shorter term returns across the past week and month. See our latest analysis for Mueller Water Products. At a share price of $27.39, the stock has given up some ground in the past week and month. However, the year to date share price return of 14.41% and multi year total...
NYSE:BROS
NYSE:BROSHospitality

Dutch Bros Tests Summer Energy Drinks As North Carolina Growth Accelerates

Dutch Bros (NYSE:BROS) has rolled out its new Myst Energy Refreshers summer drink line across its system. The company is also preparing a new shop in Wilson, North Carolina, continuing its recent push into the state. These moves highlight Dutch Bros' focus on growing customer traffic through new products and a wider US footprint. Dutch Bros enters this news cycle with a share price of $56.95 and a value score of 1. The stock shows mixed recent performance, with a 12.6% return over the past...
NYSE:FHI
NYSE:FHICapital Markets

Federated Hermes (FHI) Margins At 20.5% Challenge Cautious Earnings Narratives

Federated Hermes (FHI) opened 2026 with Q1 results that put the focus squarely on its income statement, reporting total revenue of US$479 million and basic EPS of US$1.33, underpinned by net income of US$96 million. Over the past six reported quarters, revenue has ranged from US$425 million in Q1 2025 to US$483 million in Q4 2025, while quarterly basic EPS has moved between US$1.04 in Q4 2024 and US$1.39 in Q4 2025. This gives a clear view of how the current print fits into the recent run...
NasdaqGS:QLYS
NasdaqGS:QLYSSoftware

Is It Time To Reconsider Qualys (QLYS) After Its Recent Share Price Slide

If you are wondering whether Qualys is starting to look like value at its current share price, or if the recent moves are a warning sign, this article walks you through what the numbers actually say. The stock last closed at US$88.53, with a 5.0% gain over the past week and a 2.7% move over the last month, set against a 32.4% decline year to date and a 30.8% decline over the past year. These returns sit alongside ongoing interest in cybersecurity providers and recurring revenue models, which...
NasdaqGS:ZG
NasdaqGS:ZGReal Estate

Zillow Lead Shift Favors Big Teams And Raises Investor Questions

Zillow Group (NasdaqGS:ZG) is adjusting its lead distribution system, with recent changes favoring large, high volume agent teams. Agents that do not meet Zillow's preapproval benchmarks, particularly around Zillow Home Loans, face potential risks to their Flex or Preferred status. The shift is creating friction within parts of Zillow's agent network, raising questions about future engagement and business growth on the platform. Zillow Group, through its flagship real estate marketplace and...
NYSE:BFLY
NYSE:BFLYMedical Equipment

The Bull Case For Butterfly Network (BFLY) Could Change Following Q1 2026 Results And New CMO Appointment

In the first quarter of 2026, Butterfly Network, Inc. reported revenue of US$26.53 million versus US$21.23 million a year earlier, with its net loss narrowing to US$12.68 million from US$13.97 million, while also slightly improving basic and diluted loss per share from continuing operations to US$0.05 from US$0.06. Earlier in April 2026, the company appointed Arun Nagdev, MD as Chief Medical Officer – POCUS, adding deep clinical, ultrasound, and AI product expertise to guide its global...
NYSE:RTX
NYSE:RTXAerospace & Defense

A Look At RTX (NYSE:RTX) Valuation After Recent Share Price Weakness And Backlog Growth Expectations

RTX stock moves and recent performance snapshot RTX (RTX) shares recently traded around $173.99, with the stock showing a 1-day return of about a 1.18% decline and a 1-month performance near a 10.65% decline, while the past 3 months reflect roughly a 13.41% decline. See our latest analysis for RTX. RTX’s recent share price return has been weak over the past quarter and year to date. However, the 1 year and 5 year total shareholder returns of 35.88% and 127.03% show a very different picture of...
NYSE:WU
NYSE:WUDiversified Financial

Is It Time To Reassess Western Union (WU) After Its Recent Share Price Rebound

If you are wondering whether Western Union is currently priced for opportunity or risk, this article will walk you through what the current share price might be implying about the stock's value. The stock last closed at US$9.21, with returns of 3.5% over the past week, 8.9% over the past month, 5.3% over the past year, and a small 0.2% decline year to date. This performance raises questions about how much of the story is already reflected in the price. Recent coverage around Western Union...
NYSE:NET
NYSE:NETIT

Is It Too Late To Consider Cloudflare (NET) After A 393% Three Year Surge?

If you are wondering whether Cloudflare's current share price lines up with its underlying worth, this article walks through what the numbers actually say about value. With the stock at around US$217.50 and returns of 5.0% over 7 days, 5.9% over 30 days, 11.0% year to date, 75.1% over 1 year and 393.5% over 3 years, many investors are asking if the recent performance still leaves room for an attractive entry point or instead signals a higher level of risk. Recent headlines have focused on...
NYSE:DAR
NYSE:DARFood

Has Darling Ingredients (DAR) Rally Left Room After Renewable Fuels Spotlight On Valuation?

If you are wondering whether Darling Ingredients at US$63.77 is offering fair value right now or if the price has already run ahead of the story, this article breaks down what the market may be pricing in. The stock has returned 6.0% over the last 7 days, 2.6% over the last month, 69.4% year to date, and 95.9% over the last year, figures that can change how investors think about both upside and risk. Recent news coverage has focused on how the company fits into broader themes in food, waste...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

A Look At Wave Life Sciences (WVE) Valuation After Q1 2026 Results And RNA Pipeline Progress

Wave Life Sciences (WVE) drew investor attention after reporting first quarter 2026 results, with sales of US$38.25 million, a net loss of US$26.09 million, and progress across several RNA based clinical programs. See our latest analysis for Wave Life Sciences. Despite the earnings beat and clinical updates, the recent 7.17% 1 month share price return to US$7.32 comes after a much steeper 43.43% 3 month share price decline. The 3 year total shareholder return of 83.46% contrasts with a 9.63%...
NYSE:DLB
NYSE:DLBSoftware

Dolby Laboratories (DLB) Margin Compression Challenges Bullish Earnings Growth Narrative In Q2 2026

Dolby Laboratories (DLB) has put up a solid Q2 2026 scorecard, with revenue of US$395.6 million and basic EPS of US$1.00, setting a clear marker for how the year is shaping up. Over the past few quarters the company has seen revenue move from US$356.999 million in Q1 2025 to US$369.561 million in Q2 2025, then to US$346.706 million in Q1 2026 and now US$395.63 million, while basic EPS tracked from US$0.71 to US$0.95, then US$0.56 and now just under US$1.00. With a trailing twelve month net...
NYSE:FUL
NYSE:FULChemicals

Is It Time To Reconsider H.B. Fuller (FUL) After Recent Share Price Pullback?

For investors considering whether H.B. Fuller is currently priced attractively or if the recent share price leaves limited potential upside, this article focuses on what the current valuation suggests. The stock last closed at US$59.95, with a 12.1% return over the past year. However, recent 7-day and 30-day returns of 4.6% and 4.0% declines, along with a small 0.6% decline year to date, indicate that sentiment has been more cautious lately. Recent coverage has centered on how H.B. Fuller is...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Assessing Core Scientific (CORZ) Valuation As Texas AI Expansion And New Financing Draw Interest

Why Core Scientific’s latest financing and Texas build out matter for stock watchers Core Scientific (CORZ) is in focus after its financing arm completed a US$3.3b senior secured notes offering due 2031, alongside plans to expand its Pecos, Texas campus for high density AI colocation. See our latest analysis for Core Scientific. At a share price of US$20.35, Core Scientific has recorded a 33.01% 1 month share price return and a 27.27% year to date share price return, while its 1 year total...
NYSE:OVV
NYSE:OVVOil and Gas

Do Rising Estimates and Big Holders Mask a More Nuanced Ovintiv (OVV) Valuation Story?

In recent days, Ovintiv has attracted growing attention as analysts broadly raised their earnings estimates for the next quarter and full year, while major institutional holders such as Vanguard disclosed multi-million-share, passive stakes in the company. This combination of upgraded earnings expectations, continued bullish analyst views, and concentrated institutional ownership has sharpened the focus on how Ovintiv’s fundamentals align with differing assessments of its intrinsic value and...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Critical Metals Nears Full Tanbreez Control With Ownership And Risk Focus

Critical Metals (NasdaqGM:CRML) has increased its stake in Tanbreez Mining Greenland to 92.5%. The company has entered into an agreement with European Lithium to acquire the remaining minority interest. The transaction moves Critical Metals closer to full ownership of one of the largest rare earth projects globally. For investors watching the rare earths space, Critical Metals, ticker NasdaqGM:CRML, now holds a 92.5% stake in Tanbreez Mining Greenland and has a path toward full control. The...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

A Look At Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Weakness

What recent performance signals about Regeneron Pharmaceuticals (REGN) With no single headline event driving Regeneron Pharmaceuticals (REGN) today, the stock’s recent performance and current fundamentals offer a useful starting point if you are tracking large cap US biotech names. Regeneron closed at US$701.42, with shares showing a 0.8% decline over the past day and a 6.7% decline over the past week. The stock is also down about 9.8% over the past month and 5.4% over the past 3 months,...
NYSE:BK
NYSE:BKCapital Markets

Assessing Bank of New York Mellon Corporation (BK) Valuation After Strong Multi‑Period Share Price Gains

Bank of New York Mellon Corporation (BK) has been drawing attention after its recent share performance, with returns of about 11% over the past 3 months and roughly 14% year to date. See our latest analysis for Bank of New York Mellon. The recent 10.6% 30 day share price return, on top of a 14.3% year to date move, sits against a much stronger backdrop, with 1 year total shareholder return of 65.9% and very large 3 year gains. This suggests momentum has been building over time, even if the...